Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

In Vitro Drug Dissolution: Compendial Testing Models I

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sequence-Defined Digital Bottlebrush Polymers for Programmable Oligonucleotide Delivery.

bioRxiv : the preprint server for biology·2026

Same author

Understanding Size Distributions during Lipid Nanoparticle Manufacturing through Mechanistic Modeling.

ACS omega·2026

Same author

Systems analysis of the kinetics of in vitro transcription from interactions of T7 RNA polymerase and DNA.

Archives of biochemistry and biophysics·2026

Same author

End-to-end digital twin software for continuous mRNA manufacturing.

International journal of pharmaceutics·2025

Same author

Transepidermal water loss increases during murine food anaphylaxis and reflects reaction severity.

Frontiers in immunology·2025

Same author

Model-Based Optimization of Fed-Batch In Vitro Transcription.

Chembiochem : a European journal of chemical biology·2025

Same journal

Leveraging Carnitine-functionalized Lipid Nanocarrier based Targeted Delivery of A1874 PROTAC for Glioblastoma.

Pharmaceutical research·2026

Same journal

Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling.

Pharmaceutical research·2026

Same journal

Sustained Intra-Articular Delivery of Triple Therapeutics Using a Phase-Transition Phospholipid-Based Gel for Effective Treatment of Gouty Arthritis.

Pharmaceutical research·2026

Same journal

Spray Dried Lysozyme Microspheres: Morphological Evolution and Enzymatic Activity Retention.

Pharmaceutical research·2026

Same journal

Colloidal Stability of Amorphous Nanoparticles in Solution: Impact of Stabilizer.

Pharmaceutical research·2026

Same journal

Impact of Mixing Approach and Bubble Formation on In Situ Forming Implant Properties.

Pharmaceutical research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 5, 2026

Formation of Dispersible Taohong Siwu Tablets

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified?

Mohammad A Azad^1,2, Juan G Osorio^1,3, Allison Wang¹

¹Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, Massachusetts, 02139, USA.

Pharmaceutical Research

|October 26, 2019

Summary

This summary is machine-generated.

A new miniature platform enables on-demand manufacturing of direct compressible tablets using minimal excipients for APIs. This automated system simplifies formulation and reduces time-to-market, meeting quality standards without long-term stability needs.

Keywords:

direct compressible tablets formulation simplification integrated pharmaceutical manufacturing on-demand manufacturing oral solid dosage

More Related Videos

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding

Published on: June 27, 2014

Rapid Manufacturing of Thin Soft Pneumatic Actuators and Robots

Rapid Manufacturing of Thin Soft Pneumatic Actuators and Robots

Published on: November 8, 2019

Related Experiment Videos

Last Updated: Jan 5, 2026

Formation of Dispersible Taohong Siwu Tablets

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding

Published on: June 27, 2014

Rapid Manufacturing of Thin Soft Pneumatic Actuators and Robots

Rapid Manufacturing of Thin Soft Pneumatic Actuators and Robots

Published on: November 8, 2019

Area of Science:

Pharmaceutical Manufacturing
Drug Delivery Systems
Materials Science

Background:

Oral direct compressible tablets are the most common dosage form, requiring careful excipient selection for manufacturability, stability, and bioavailability.
Traditional tablet manufacturing involves complex formulation development with numerous excipients.
Active pharmaceutical ingredients (APIs) necessitate specific excipient profiles for successful drug product development.

Purpose of the Study:

To investigate formulation simplification for direct compressible tablets using a minimal number of excipients.
To evaluate an on-demand, miniature manufacturing platform for direct compressible tablets.
To assess the feasibility of producing tablets for APIs where long-term stability is not a primary concern.

Main Methods:

Five different APIs (Diazepam, Diphenhydramine HCl, Doxycycline Monohydrate, Ibuprofen, Ciprofloxacin HCl) were formulated into direct compressible tablets.
Tablets were manufactured using direct compression in a small-scale, automated system.
Critical quality attributes (CQAs) were assessed against United States Pharmacopeia (USP) standards, including accelerated stability testing.

Main Results:

The miniature system successfully produced on-demand tablets from crystalline APIs with a minimal excipient set.
All manufactured tablets met USP quality standards post-production.
Tablets maintained quality after two weeks of accelerated stability testing, with a minor noted decrease in Ibuprofen drug release.

Conclusions:

On-demand tablet manufacturing using a flexible, miniature, automated system simplifies pharmaceutical formulation design for applications not requiring long-term stability.
This approach offers significant economic advantages through reduced product time-to-market.
The system enhances drug product quality and manufacturing efficiency.